Fulcrum Therapeutics, Inc. Contracts & Agreements
56 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (4)
- Human Resources (34)
- Intellectual Property (3)
- Real Estate (1)
- Uncategorized (1)
- Form of Pre-Funded Warrant (Filed With SEC on August 22, 2024)
- Employment Agreement, dated March 18, 2024, by and between the Registrant and Patrick Horn (Filed With SEC on May 13, 2024)
- Second Amendment to 2022 Inducement Stock Incentive Plan (Filed With SEC on February 27, 2024)
- Employment Agreement, dated August 7, 2023, by and between the Registrant and Alan A. Musso (Filed With SEC on November 7, 2023)
- License Agreement, effective as of July 5, 2023, by and between the Registrant and CAMP4 Therapeutics Corporation (Filed With SEC on November 7, 2023)
- Employment Agreement, dated May 12, 2023, by and between the Registrant and Alex C. Sapir (Filed With SEC on August 3, 2023)
- First Amendment to Collaboration and License Agreement, effective as of April 20, 2023, by and between the Registrant and MyoKardia, Inc., a wholly-owned subsidiary of Bristol... (Filed With SEC on August 3, 2023)
- Consulting agreement, dated April 22, 2023, by and between Registrant and Esther Rajavelu (Filed With SEC on May 15, 2023)
- Underwriting Agreement, dated January 17, 2023, by and among Fulcrum Therapeutics, Inc., Goldman Sachs & Co. LLC, SVB Securities LLC and Piper Sandler & Co. as representatives of... (Filed With SEC on January 18, 2023)
- Underwriting Agreement, dated August 15, 2022, by and among Fulcrum Therapeutics, Inc., Goldman Sachs & Co. LLC, and SVB Securities LLC as representatives of the several... (Filed With SEC on August 17, 2022)
- Employment Agreement by and between Mel Hayes and Fulcrum Therapeutics, Inc., dated as of September 7, 2021 (Filed With SEC on August 11, 2022)
- Equity Distribution Agreement, dated May 9, 2022, by and between the Company and Piper Sandler & Co (Filed With SEC on May 10, 2022)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on March 3, 2022)
- Form of Restricted Stock Unit Agreement under the 2019 Stock Incentive Plan (Filed With SEC on March 3, 2022)
- 2022 Inducement Stock Incentive Plan (Filed With SEC on March 3, 2022)
- Form of Non-Statutory Stock Option Agreement under 2022 Inducement Stock Incentive Plan (Filed With SEC on March 3, 2022)
- Form of Restricted Stock Unit Agreement under 2022 Inducement Stock Incentive Plan (Filed With SEC on March 3, 2022)
- Employment Agreement, dated January 3, 2022, by and between the Registrant and Esther Rajavelu (Filed With SEC on March 3, 2022)
- Form of Inducement Stock Option Agreement (Filed With SEC on November 4, 2021)
- Underwriting Agreement, dated August 11, 2021, by and among the Company and SVB Leerink LLC, Piper Sandler & Co. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on August 12, 2021)
- Employment Agreement, dated May 10, 2021, by and between the Registrant and Christopher Morabito (Filed With SEC on August 10, 2021)
- Employment Agreement, dated March 31, 2021, by and between the Registrant and Bryan Stuart (Filed With SEC on May 6, 2021)
- Consulting Agreement, dated March 31, 2021, by and between the Registrant and Robert J. Gould (Filed With SEC on May 6, 2021)
- Employment Agreement, dated March 19, 2021, by and between the Registrant and Judith Dunn (Filed With SEC on May 6, 2021)
- Employment Agreement, dated February 6, 2021, by and between the Registrant and Christopher Moxham (Filed With SEC on May 6, 2021)
- Employment Agreement, dated October 29, 2020, by and between the Registrant and Curtis Oltmans (Filed With SEC on March 4, 2021)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on March 4, 2021)
- Underwriting Agreement, January 19, 2021, by and among the Company and SVB Leerink LLC, Piper Sandler & Co. and Credit Suisse Securities (USA) LLC (Filed With SEC on January 20, 2021)
- First Amendment to the Right of Reference and License Agreement, dated as of September 23, 2020, by and among the Registrant, GlaxoSmithKline Intellectual Property (No. 2)... (Filed With SEC on November 10, 2020)
- Collaboration and License Agreement, dated as of July 20, 2020, by and between the Registrant and MyoKardia, Inc (Filed With SEC on November 10, 2020)
- Registration Rights Agreement, dated June 9, 2020, by and among the Company and the other parties thereto (Filed With SEC on June 10, 2020)
- Securities Purchase Agreement, dated June 9, 2020, by and among the Company and the other parties thereto (Filed With SEC on June 10, 2020)
- Employment Agreement, dated July 18, 2019, by and between the Registrant and Owen Wallace (Filed With SEC on May 13, 2020)
- Collaboration and License Agreement, dated as of December 20, 2019, by and between the Registrant and Acceleron Pharma Inc (Filed With SEC on March 5, 2020)
- Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 5, 2020)
- Employment Agreement, dated June 30, 2019, by and between the Registrant and Diego Cadavid (to be effective upon the effective date of the Registration Statement) (Filed With SEC on July 12, 2019)
- Employment Agreement, dated July 3, 2019, by and between the Registrant and Bryan Stuart (to be effective upon the effective date of the Registration Statement) (Filed With SEC on July 12, 2019)
- Employment Agreement, dated June 30, 2019, by and between the Registrant and Robert J. Gould (to be effective upon the effective date of the Registration Statement) (Filed With SEC on July 12, 2019)
- Form of Stock Option Agreement under the 2019 Stock Incentive Plan (Filed With SEC on July 8, 2019)
- 2019 Stock Incentive Plan (Filed With SEC on July 8, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on July 8, 2019)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on July 8, 2019)
- Form of Employment Agreement for Executive Officers (Filed With SEC on July 8, 2019)
- Form of Underwriting Agreement (Filed With SEC on June 21, 2019)
- Form of Indemnification Agreement between the Registrant and each of its Executive Officers and Directors (Filed With SEC on June 21, 2019)
- Offer of Employment, dated August 10, 2016, by and between the Registrant and Diego Cadavid (Filed With SEC on June 21, 2019)
- Offer of Employment, dated December 6, 2018, by and between the Registrant and Bryan Stuart (Filed With SEC on June 21, 2019)
- Offer of Employment, dated June 13, 2016, by and between the Registrant and Robert Gould (Filed With SEC on June 21, 2019)
- Lease for 26 Landsdowne Street, dated November 22, 2017, by and between the UP 26 Landsdowne, LLC and the Registrant (Filed With SEC on June 21, 2019)
- Right of Reference and License Agreement, dated as of February 8, 2019, by and among the Registrant, GlaxoSmithKline Intellectual Property (No. 2) Limited, GlaxoSmithKline LLC and... (Filed With SEC on June 21, 2019)
- Form of Restricted Stock Agreement under the 2016 Stock Incentive Plan (Filed With SEC on June 21, 2019)
- Form of Non-Statutory Stock Option Agreement under the 2016 Stock Incentive Plan (Filed With SEC on June 21, 2019)
- Form of Incentive Stock Option Agreement under the 2016 Stock Incentive Plan (Filed With SEC on June 21, 2019)
- 2016 Stock Incentive Plan, as amended (Filed With SEC on June 21, 2019)
- Amended and Restated Investors' Rights Agreement, dated as of August 24, 2018, by and among the Registrant and the other parties thereto (Filed With SEC on June 21, 2019)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on June 21, 2019)
